Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.8400 (0.73%) ($13.5500 - $13.9100) on Fri. Nov. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.11% (three month average) | RSI | 67 | Latest Price | $13.8400(0.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.055% in a week (0% probabilities). VIXM(-36%) VXX(-35%) TLT(-11%) UNG(-7%) UUP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.055% (StdDev 4.11%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $13.96(-0.86%) | 10 Day Moving Average | $13.56(2.06%) | 20 Day Moving Average | $12.91(7.2%) | To recent high | -14.8% | To recent low | 27.1% | Market Cap | $1.028b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |